SJ Medical
SJ Medical
The global landscape of Mitral Valve Repair Devices is undergoing a seismic shift. Mitral Regurgitation (MR) remains one of the most prevalent heart valve diseases worldwide, affecting millions of patients. Historically, open-heart surgery was the gold standard; however, the emergence of Transcatheter Mitral Valve Repair (TMVr) has revolutionized the industry. Today, the demand for minimally invasive devices, such as transcatheter edge-to-edge repair (TEER) systems and annuloplasty rings, is skyrocketing in North America, Europe, and increasingly in the Asia-Pacific region.
Leading suppliers are now focusing on enhancing hemodynamic performance and reducing procedural complexity. As a premier medical device factory, we recognize that the integration of sophisticated imaging and precision delivery systems is what separates top-tier manufacturers from the rest of the market. The global industry value is projected to reach billions by 2030, driven by an aging population and the rapid adoption of interventional cardiology techniques.
Focusing on biocompatible materials and micro-catheter technologies to ensure maximum safety during complex cardiac procedures.
A significant transition from surgical replacement to minimally invasive repair, reducing recovery time and hospital stays for patients.
Hospitals and distributors are seeking reliable OEM/ODM partners in China who can deliver CE-certified, high-performance cardiac devices.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
Different markets have distinct needs when it comes to Mitral Valve Repair. In developed markets like the EU and USA, the focus is on high-tech integration, such as 3D echocardiography-compatible delivery systems. In emerging markets like India, Brazil, and parts of the Middle East, the priority is on balancing clinical efficacy with cost-efficiency—a niche where our Chinese factory excels.
Our products, ranging from balloon catheters to access sheaths, are designed for versatile application scenarios:
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
Our production equipment is at the forefront of the industry, including:
Advanced laser welding and marking technologies ensure the structural integrity of every valve repair component.
Comprehensive laboratory facilities for fatigue testing, biocompatibility verification, and flow simulation.
Precision balloon forming equipment tailored for the specific pressures required in cardiovascular interventions.
As we look toward the future, the top mitral valve repair device manufacturers are those who embrace AI-assisted sizing and patient-specific implant designs. At Hangzhou SJ Medical, we are not just a supplier; we are a partner in innovation. By combining our robust manufacturing capabilities with a deep understanding of hemodynamic clinical needs, we are helping to shape the next generation of cardiac care.
Whether you are a global distributor looking for a competitive edge or a healthcare provider seeking the most reliable interventional tools, our team is ready to deliver. Our global market presence, spanning from Italy and France to Turkey and India, stands as a testament to our reliability and authority in the medical device sector.
